1. Home
  2. COLD vs FOLD Comparison

COLD vs FOLD Comparison

Compare COLD & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.80

Market Cap

3.1B

Sector

Real Estate

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$10.75

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
FOLD
Founded
1903
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
COLD
FOLD
Price
$12.80
$10.75
Analyst Decision
Buy
Buy
Analyst Count
14
7
Target Price
$15.93
$30.29
AVG Volume (30 Days)
7.6M
4.6M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
7.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,407,000.00
$598,704,000.00
Revenue This Year
N/A
$21.49
Revenue Next Year
N/A
$18.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.28
52 Week Low
$10.10
$5.51
52 Week High
$23.52
$11.00

Technical Indicators

Market Signals
Indicator
COLD
FOLD
Relative Strength Index (RSI) 67.28 77.41
Support Level $10.51 $9.73
Resistance Level $11.33 $10.05
Average True Range (ATR) 0.45 0.36
MACD 0.32 0.04
Stochastic Oscillator 96.90 77.53

Price Performance

Historical Comparison
COLD
FOLD

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: